Pediatric Nailing Platform Femur
ORTHOPEDIATRICS CORP. · Decision date Sep 24, 2026
What did the FDA decide?
FDA's September 24, 2026 letter for K261345 records a substantial-equivalence determination for OrthoPediatrics Corp.'s Pediatric Nailing Platform | Femur. The summary describes nails, screws, end caps and condylar nuts made in 316L stainless steel or Ti-6Al-4V ELI titanium alloy, with antegrade and retrograde nail configurations. FDA lists Class II, regulation 888.3020 and product code HSB.
The summary's technological comparison specifically names K250623 as the predicate Pediatric Nailing Platform | Femur. Its predicate section also lists K220679 and K172583 for that device family, a DePuy Synthes secondary predicate and a Pega Medical reference device. These roles are distinct. The summary reports mechanical evaluations under ASTM F543 and F1264, but the available excerpts do not identify every technological difference or give numerical test results. This account reports the documented device and comparison structure without treating each listed clearance as the same predicate.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Sep 24, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261345
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- ORTHOPEDIATRICS CORP.
- Product code
- HSB
- Decision code
- SESE
- Decision date
- Sep 24, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Rod, Fixation, Intramedullary And Accessories.
- Applicant
- ORTHOPEDIATRICS CORP.
- Product code
- HSB
- FDA device class
- 2
FDA decision timeline
K261345 received
Application receipt date recorded by FDA.
K261345 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code HSB
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| McGinley Orthopaedic Innovations | 510(k) clearance | Oct 19, 2026 | FDA | |
| STRYKER GmbH | 510(k) clearance | Jun 29, 2026 | FDA | |
| Suzhou and Science & Technology Development Corp. | 510(k) clearance | Jun 18, 2026 | FDA | |
| NuVasive Specialized Orthopedics | 510(k) clearance | Jun 18, 2026 | FDA | |
| Beijing Fule Science & Technology Development Co., Ltd. | 510(k) clearance | Jun 17, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
ORTHOPEDIATRICS CORP.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Warsaw, IN
Sources and methodology
- Original FDA record: K261345
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

